Literature DB >> 16596413

Live cell imaging of phagosome maturation in Staphylococcus aureus infected human endothelial cells: small colony variants are able to survive in lysosomes.

Andreas Schröder1, Raphael Kland, Andreas Peschel, Christof von Eiff, Martin Aepfelbacher.   

Abstract

Small colony variants (SCVs) of Staphylococcus aureus have been proposed to persist within vascular endothelium, thereby sustaining chronic infections. To identify the intracellular SCV location we infected primary human endothelial cells with various wild type and SCV strains of S. aureus and visualised maturation of phagosomes using live cell imaging. Staphylococci-containing phagosomes were matured by sequential and dynamic interactions with Rab5- and Rab7-positive vesicles. Within 45-60 min all internalised staphylococci accumulated in LAMP-1- and LysoTracker-enriched lysosomal organelles and remained there for up to 5 days. Recovery of most staphyloccocal strains was below 1% after a 24 h intracellular stay, indicating a high bactericidal activity of the endothelial cell lysosomes. However, the menadione auxotroph SCV strain JB1 displayed a recovery rate of 4% and, furthermore, through multiple intracellular passaging a subtype (JB1-P4) with a recovery rate of 25-30% could be generated. Interestingly, both JB1 and JB1-P4 also resided exclusively in lysosomes. Thus, on one hand we document effective bactericidal activity of human endothelial cell lysosomes towards staphylococci, and on the other hand we provide evidence that certain SCVs are capable to withstand this activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596413     DOI: 10.1007/s00430-006-0015-0

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  29 in total

Review 1.  Rab proteins as membrane organizers.

Authors:  M Zerial; H McBride
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

Review 2.  Controlling the maturation of pathogen-containing vacuoles: a matter of life and death.

Authors:  S Méresse; O Steele-Mortimer; E Moreno; M Desjardins; B Finlay; J P Gorvel
Journal:  Nat Cell Biol       Date:  1999-11       Impact factor: 28.824

Review 3.  Phagosome maturation: aging gracefully.

Authors:  Otilia V Vieira; Roberto J Botelho; Sergio Grinstein
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

4.  Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture.

Authors:  J Heesemann; R Laufs
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

5.  Intravital fluorescence microscopy: a novel tool for the study of the interaction of Staphylococcus aureus with the microvascular endothelium in vivo.

Authors:  Matthias W Laschke; Sylvain Kerdudou; Mathias Herrmann; Michael D Menger
Journal:  J Infect Dis       Date:  2004-12-28       Impact factor: 5.226

6.  Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease.

Authors:  C von Eiff; K Becker; D Metze; G Lubritz; J Hockmann; T Schwarz; G Peters
Journal:  Clin Infect Dis       Date:  2001-04-30       Impact factor: 9.079

7.  Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells.

Authors:  K W Bayles; C A Wesson; L E Liou; L K Fox; G A Bohach; W R Trumble
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

8.  Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells.

Authors:  M Essler; M Amano; H J Kruse; K Kaibuchi; P C Weber; M Aepfelbacher
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

9.  Highly resistant metabolically deficient dwarf mutant of Escherichia coli is the cause of a chronic urinary tract infection.

Authors:  Konrad Trülzsch; Harald Hoffmann; Christiane Keller; Sören Schubert; Lutz Bader; Jürgen Heesemann; Andreas Roggenkamp
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis.

Authors:  Yok-Ai Que; Jacques-Antoine Haefliger; Lionel Piroth; Patrice François; Eleonora Widmer; José M Entenza; Bhanu Sinha; Mathias Herrmann; Patrick Francioli; Pierre Vaudaux; Philippe Moreillon
Journal:  J Exp Med       Date:  2005-05-16       Impact factor: 14.307

View more
  30 in total

1.  Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850.

Authors:  Thiên-Trí Lâm; Bernd Giese; Deepak Chikkaballi; Anika Kühn; Wanja Wolber; Jan Pané-Farré; Daniel Schäfer; Susanne Engelmann; Martin Fraunholz; Bhanu Sinha
Journal:  Infect Immun       Date:  2010-06-07       Impact factor: 3.441

Review 2.  Antistaphylococcal vaccines and immunoglobulins: current status and future prospects.

Authors:  Stan Deresinski
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.

Authors:  Anne Sandberg; Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens; Diarmaid Hughes; Christof von Eiff; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

4.  The Staphylococcus aureus epidermal cell differentiation inhibitor toxin promotes formation of infection foci in a mouse model of bacteremia.

Authors:  Patrick Munro; Maxime Benchetrit; Marie-Anne Nahori; Caroline Stefani; René Clément; Jean-François Michiels; Luce Landraud; Olivier Dussurget; Emmanuel Lemichez
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

5.  Staphylococcal alpha-toxin is not sufficient to mediate escape from phagolysosomes in upper-airway epithelial cells.

Authors:  Bernd Giese; Silvia Dittmann; Kerstin Paprotka; Katja Levin; Annett Weltrowski; Diana Biehler; Thiên-Trí Lâm; Bhanu Sinha; Martin J Fraunholz
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

6.  A Network Biology Approach to Decipher Stress Response in Bacteria Using Escherichia coli As a Model.

Authors:  Shashwat Deepali Nagar; Bhavye Aggarwal; Shikha Joon; Rakesh Bhatnagar; Sonika Bhatnagar
Journal:  OMICS       Date:  2016-05

7.  Infection of polarized airway epithelial cells by normal and small-colony variant strains of Staphylococcus aureus is increased in cells with abnormal cystic fibrosis transmembrane conductance regulator function and is influenced by NF-κB.

Authors:  Gabriel Mitchell; Gilles Grondin; Ginette Bilodeau; André M Cantin; François Malouin
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

8.  A defect in menadione biosynthesis induces global changes in gene expression in Staphylococcus aureus.

Authors:  Christian Kohler; Christof von Eiff; Manuel Liebeke; Peter J McNamara; Michael Lalk; Richard A Proctor; Michael Hecker; Susanne Engelmann
Journal:  J Bacteriol       Date:  2008-08-01       Impact factor: 3.490

9.  Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection.

Authors:  Wei Gao; Kyra Chua; John K Davies; Hayley J Newton; Torsten Seemann; Paul F Harrison; Natasha E Holmes; Hyun-Woo Rhee; Jong-In Hong; Elizabeth L Hartland; Timothy P Stinear; Benjamin P Howden
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

10.  Gamma interferon confers resistance to infection with Staphylococcus aureus in human vascular endothelial cells by cooperative proinflammatory and enhanced intrinsic antibacterial activities.

Authors:  Henry Beekhuizen; Joke S van de Gevel
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.